Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Neumann

Showing results (241-250 of 301) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugsScott R Berry, Chaim M Bell, Peter A Ubel, et al.
The American Journal of Managed Care|January 13, 2006
Do drug formulary policies reflect evidence of value?Peter J Neumann, Pei-Jung Lin, Dan Greenberg, et al.
Health Affairs (Project Hope)|January 8, 2019
Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic EfficiencyDavid D Kim, Joshua T Cohen, John B Wong, et al.
Annals of Internal Medicine|January 4, 2018
Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness AnalysisVaibhav Kumar, Joshua T Cohen, David van Klaveren, et al.
Health Affairs (Project Hope)|January 14, 2005
Medicare's national coverage decisions, 1999-2003: quality of evidence and review timesPeter J Neumann, Nomita Divi, Molly T Beinfeld, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 2, 2012
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United StatesJalpa A Doshi, Paul Hodgkins, Jennifer Kahle, et al.
Blood|February 7, 2015
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analysesCayla J Saret, Aaron N Winn, Gunjan Shah, et al.
Journal of Occupational and Environmental Medicine|July 17, 2012
Imputing productivity gains from clinical trialsMichael J Cangelosi, Sarah Bliss, Hong Chang, et al.
Journal of Alzheimer'S Disease : JAD|June 19, 2025
Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United StatesPei-Jung Lin, Abigail G Riley, Patricia G Synnott, et al.
Health Economics|January 25, 2012
Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residentsPeter J Neumann, Joshua T Cohen, James K Hammitt, et al.
Pageof 31

Showing results (241-250 of 301) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugsScott R Berry, Chaim M Bell, Peter A Ubel, et al.
The American Journal of Managed Care|January 13, 2006
Do drug formulary policies reflect evidence of value?Peter J Neumann, Pei-Jung Lin, Dan Greenberg, et al.
Health Affairs (Project Hope)|January 8, 2019
Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic EfficiencyDavid D Kim, Joshua T Cohen, John B Wong, et al.
Annals of Internal Medicine|January 4, 2018
Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness AnalysisVaibhav Kumar, Joshua T Cohen, David van Klaveren, et al.
Health Affairs (Project Hope)|January 14, 2005
Medicare's national coverage decisions, 1999-2003: quality of evidence and review timesPeter J Neumann, Nomita Divi, Molly T Beinfeld, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 2, 2012
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United StatesJalpa A Doshi, Paul Hodgkins, Jennifer Kahle, et al.
Blood|February 7, 2015
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analysesCayla J Saret, Aaron N Winn, Gunjan Shah, et al.
Journal of Occupational and Environmental Medicine|July 17, 2012
Imputing productivity gains from clinical trialsMichael J Cangelosi, Sarah Bliss, Hong Chang, et al.
Journal of Alzheimer'S Disease : JAD|June 19, 2025
Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United StatesPei-Jung Lin, Abigail G Riley, Patricia G Synnott, et al.
Health Economics|January 25, 2012
Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residentsPeter J Neumann, Joshua T Cohen, James K Hammitt, et al.
Pageof 31